Revenue breakdown: Canada Cannabis (26.9%), Canadian Cannabis Net Revenue (26.2%), Canadian Medical Cannabis Net Revenue (26.2%).
8-K
Canopy Growth Corporation completed its acquisition of all issued and outstanding shares of MTL Cannabis Corp. on March 16, 2026, issuing approximately 41.2 million Canopy Growth Shares and $18.5 million in cash, plus 2,956,391 shares to former MC shareholders. This establishes Canada's leading medical cannabis business by revenue, enhances flower supply for international markets, and integrates MTL's leadership including Mike Perron as COO.